China Updates Penalty, Inspection Regs in Wake of Pharma Industry Probe

Written on:October 8, 2013
Comments are closed

The China Food and Drug Administration is asking the public to comment on proposed revisions to its regulations and penalties related to inspections and investigations, an apparent response to the ongoing bribery scandal that has rocked the pharmaceutical industry.

Source: International Pharmaceutical Regulatory Monitor


Sorry, the comment form is closed at this time.